All Categories
All New Open Closed
Insider 1 Catalyst 4 Earnings 3 Contrarian 1 Macro 3 Alpha 11
Published today Free pick Click a pick for full details
Avg PnL+5.51%Avg vs S&P+6.02%(1 pick)
CC OPEN FREE PICK Chart
Chemours Company
Contrarian Industrials Mid cap 8/10/26 (20d ago) HOLD
Hold2-4 weeks
Entry$14.80Now$15.61PnL+5.51%
HOLD
66%
conf

Angle Chemours is being valued at 7x forward earnings after a post-Q2 washout, versus a chemical-peer norm near 13x.

Chemours sold off sharply after Q2, with the stock dropping about 16.7% to $14.93 following missed revenue and earnings estimates [#21]. The reversal case is valuation-driven: at $16.61, Chemours was framed as trading around 7x next-year earnings versus a typical chemicals multiple near 13x, implying fair value near $29 [#30].
Catalyst A short-horizon re-rating can come from bargain buying after the Q2 earnings washout as investors reassess the multiple gap.
HOLD AI Status: Chemours shows early stabilization as daily momentum and stochastics improve, though the broader downtrend and bearish DMI cross keep the valuation-reversal setup watchful.
Avg PnL+5.51%Avg vs S&P+6.02%(1 pick)
Ticker Name Sector Category Status Hold Conf. Entry Current PnL Published
CC Chemours Company Industrials Contrarian HOLD 2-4 weeks 66% $14.80 $15.61 +5.51% 20d ago